Dalbeth Nicola, Zhong Cathy S, Grainger Rebecca, Khanna Dinesh, Khanna Puja P, Singh Jasvinder A, McQueen Fiona M, Taylor William J
From the Department of Medicine, University of Auckland, Auckland; Department of Medicine, University of Otago, Wellington, New Zealand; Division of Rheumatology, University of Michigan, Ann Arbor, Michigan; and Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama, USA.
J Rheumatol. 2014 Mar;41(3):558-68. doi: 10.3899/jrheum.131244. Epub 2013 Dec 15.
Five core domains have been endorsed by Outcome Measures in Rheumatology (OMERACT) for acute gout: pain, joint swelling, joint tenderness, patient global assessment, and activity limitation. We evaluated instruments for these domains according to the OMERACT filter: truth, feasibility, and discrimination.
A systematic search strategy for instruments used to measure the acute gout core domains was formulated. For each method, articles were assessed by 2 reviewers to summarize information according to the specific components of the OMERACT filter.
Seventy-seven articles and abstracts met the inclusion criteria. Pain was most frequently reported (76 studies, 20 instruments). The pain instruments used most often were 100 mm visual analog scale (VAS) and 5-point Likert scale. Both methods have high feasibility, face and content validity, and within- and between-group discrimination. Four-point Likert scales assessing index joint swelling and tenderness have been used in numerous acute gout studies; these instruments are feasible, with high face and content validity, and show within- and between-group discrimination. Five-point Patient Global Assessment of Response to Treatment (PGART) scales are feasible and valid, and show within- and between-group discrimination. Measures of activity limitations were infrequently reported, and insufficient data were available to make definite assessments of the instruments for this domain.
Many different instruments have been used to assess the acute gout core domains. Pain VAS and 5-point Likert scales, 4-point Likert scales of index joint swelling and tenderness and 5-point PGART instruments meet the criteria for the OMERACT filter.
风湿病疗效评估指标(OMERACT)认可的急性痛风的五个核心领域为:疼痛、关节肿胀、关节压痛、患者整体评估和活动受限。我们根据OMERACT筛选标准评估了用于这些领域的工具:真实性、可行性和区分度。
制定了用于测量急性痛风核心领域的工具的系统检索策略。对于每种方法,由两名评审员评估文章,以根据OMERACT筛选标准的具体组成部分总结信息。
77篇文章和摘要符合纳入标准。疼痛是最常被报道的(76项研究,20种工具)。最常使用的疼痛评估工具是100毫米视觉模拟量表(VAS)和5点李克特量表。这两种方法都具有高可行性、表面效度和内容效度,以及组内和组间区分度。在众多急性痛风研究中使用了评估指标关节肿胀和压痛的4点李克特量表;这些工具可行,具有高表面效度和内容效度,并显示出组内和组间区分度。5点患者对治疗反应的整体评估(PGART)量表可行且有效,并显示出组内和组间区分度。活动受限的测量方法很少被报道,并且没有足够的数据对该领域的工具进行明确评估。
许多不同的工具已被用于评估急性痛风的核心领域。疼痛VAS和5点李克特量表、指标关节肿胀和压痛的4点李克特量表以及5点PGART工具符合OMERACT筛选标准。